Reuters logo
BRIEF-Eiger announces additional phase 2 clinical trial results
April 21, 2017 / 12:34 PM / 7 months ago

BRIEF-Eiger announces additional phase 2 clinical trial results

April 21 (Reuters) - Eiger Biopharmaceuticals Inc:

* Eiger announces additional phase 2 clinical trial results for lonafarnib at the international liver congress 2017

* Eiger Biopharmaceuticals -PEG IFN to LNF 25 mg bid + rtv suppressed hdv-rna below limit of quantitation in 80% of patients, 78% achieved alt normalization Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below